Jackson Creek Investment Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Jackson Creek Investment Advisors’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$407K	Buy	+27,364	New	+$518K	0.13%	280

Other funds holding SRPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Jackson Creek Investment Advisors's SRPT Position: Q2 2026 in Review

Jackson Creek Investment Advisors opened a new position in Sarepta Therapeutics (SRPT) in Q2 2026: 27,364 shares worth $407K. The stake represents 0.13% of the portfolio and ranks #280 among its holdings.

323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

Jackson Creek Investment Advisors held 27,364 shares of Sarepta Therapeutics worth $407K as of Q2 2026.
Sarepta Therapeutics was a new Jackson Creek Investment Advisors position in Q2 2026.
Sarepta Therapeutics made up 0.13% of Jackson Creek Investment Advisors's portfolio in Q2 2026, its #280 holding.
323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.